Alpha Tau Medical Ltd (DRTS) Stock Statistics & Valuation Metrics

Alpha Tau Medical Ltd has a market cap or net worth of $260.03M. The enterprise value is $274.08M.

Alpha Tau Medical Ltd has 84,699,720 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alpha Tau Medical Ltd’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -45.90%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Alpha Tau Medical Ltd had revenue of 0.00 and earned -31.75M in profits. Earnings per share was -0.45.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Alpha Tau Medical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―

Alpha Tau Medical Ltd upcoming earnings date is ―, ―.

Alpha Tau Medical Ltd as a current ratio of 7.40, with Debt / Equity ratio of 21.83%

In the past 12 months, Alpha Tau Medical Ltd has paid 6.00K in taxes.

Alpha Tau Medical Ltd EV to EBITDA ratio is -7.12, with an EV/FCF ratio of -9.79.

Alpha Tau Medical Ltd has $51.64M in cash and marketable securities with $12.29M in debt, giving a net cash position of -$39.34M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Alpha Tau Medical Ltd is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy